ストックスクリーナーアプリを入手
7.765
2.85%
0.215
アフターアワーズ：
7.77
0.005
+0.06%
前日終値:
$7.55
開ける：
$7.765
24時間の取引高:
483
Relative Volume:
0.03
時価総額：
$37.58M
収益：
$1.28M
当期純損益:
$280.60K
株価収益率:
-10.79
EPS:
-0.7197
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.19%
1か月 パフォーマンス:
-17.74%
6か月 パフォーマンス:
-9.07%
1年 パフォーマンス:
-22.58%
1日の値動き範囲:
$7.765
$7.765
1週間の範囲:
$7.4299
$8.00
52週間の値動き範囲:
$7.19
$10.04
Daxor Corporation Stock (DXR) Company Profile
名前
Daxor Corporation
セクター
電話
212-330-8500
住所
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
DXR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
7.765 | 37.58M | 1.28M | 280.60K | 0 | -0.7197 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-05-16 | 開始されました | Ascendiant Capital Markets | Buy |
Daxor Corporation (DXR) 最新ニュース
Daxor (NYSEAMERICAN:DXR) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Daxor (NASDAQ:DXR) Shares Up 0.8% – Should You Buy? - Defense World
When (DXR) Moves Investors should Listen - Stock Traders Daily
Reviewing Embecta (NASDAQ:EMBC) and Daxor (NASDAQ:DXR) - Defense World
Daxor (NYSEAMERICAN:DXR) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
(DXR) Long Term Investment Analysis - Stock Traders Daily
Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum - GlobeNewswire
Daxor Expands Blood Analysis Service to Major Health Networks, Reports Record-Breaking Quarter - StockTitan
Daxor Expands Its BVA-100?? Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum - Marketscreener.com
Daxor corp CEO Michael Feldschuh acquires 45,000 shares By Investing.com - Investing.com Nigeria
Daxor corp CFO Michel acquires 4,750 shares at no cost By Investing.com - Investing.com Nigeria
Daxor's chief scientific officer acquires 32,000 shares By Investing.com - Investing.com Canada
Daxor's chief scientific officer acquires 32,000 shares - Investing.com
Daxor corp CFO Michel acquires 4,750 shares at no cost - Investing.com
Daxor corp CEO Michael Feldschuh acquires 45,000 shares - Investing.com
How the (DXR) price action is used to our Advantage - Stock Traders Daily
Daxor (NYSEAMERICAN:DXR) Stock Price Down 2.1% – Time to Sell? - Defense World
Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World
(DXR) On The My Stocks Page - Stock Traders Daily
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24 - The Manila Times
DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC - GlobeNewswire
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Long Term Trading Analysis for (DXR) - Stock Traders Daily
Short Interest in Daxor Co. (NASDAQ:DXR) Rises By 39.6% - Defense World
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device - The Manila Times
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024 - GlobeNewswire
Daxor (NYSEAMERICAN:DXR) Stock Passes Above Two Hundred Day Moving Average of $0.00 - Defense World
(DXR) Technical Data - Stock Traders Daily
Daxor announces review published in journal on BVA - TipRanks
Newly Published Review Highlights the Pivotal Role of - GlobeNewswire
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management - StockTitan
Daxor (NASDAQ:DXR) Price Target Raised to $24.75 at Ascendiant Capital Markets - Defense World
Daxor secures $300K from LaunchTN for blood analyzer tech - Investing.com India
Daxor receives $300K matching fund award from Launch Tennessee - TipRanks
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee - GlobeNewswire
DXRDaxor Corporation Latest Stock News & Market Updates - StockTitan
Central Florida hospital implements Daxor BVA-100 blood volume diagnostic - TipRanks
Leading Central Florida Hospital Implements Daxor’s - GlobeNewswire
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care - StockTitan
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter - GlobeNewswire
Daxor reports doubled revenue, secures government contracts - Investing.com
Daxor reports doubled revenue, secures government contracts By Investing.com - Investing.com Canada
Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time - TipRanks
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance UK
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network - GlobeNewswire
Daxor Corporation (DXR) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
0.11%
大文字化:
|
ボリューム (24 時間):